Detection of recurrent and of novel fusion transcripts in myeloid malignancies by targeted RNA sequencing
Tóm tắt
Từ khóa
Tài liệu tham khảo
Maher CA, Kumar-Sinha C, Cao X, Kalyana-Sundaram S, Han B, Jing X, et al. Transcriptome sequencing to detect gene fusions in cancer. Nature. 2009;458:97–101.
Torkildsen S, Gorunova L, Beiske K, Tjønnfjord GE, Heim S, Panagopoulos I. Novel ZEB2-BCL11B fusion gene identified by RNA-sequencing in acute myeloid leukemia with t(2;14)(q22; q32). PLoS ONE. 2015;10:e0132736.
Kuo FC, Mar BG, Lindsley RC, Lindeman NI. The relative utilities of genome-wide, gene panel, and individual gene sequencing in clinical practice. Blood. 2017;130:433–9.
Schoch C, Schnittger S, Bursch S, Gerstner D, Hochhaus A, Berger U, et al. Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases. Leukemia. 2002;16:53–9.
McGowan-Jordan J, Simons A, Schmid M. An international system for human cytogenetic nomenclature. Basel, New York: Karger; 2016.
Sakai I, Tamura T, Narumi H, Uchida N, Yakushijin Y, Hato T, et al. Novel RUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36; q22). Genes Chromosome Cancer. 2005;44:265–70.
Yang JJ, Cho SY, Suh JT, Lee HJ, Lee WI, Yoon HJ, et al. Detection of RUNX1-MECOM fusion gene and t(3;21) in a very elderly patient having acute myeloid leukemia with myelodysplasia-related changes. Ann Lab Med. 2012;32:362–5.
Chan EM, Comer EM, Brown FC, Richkind KE, Holmes ML, Chong BH, et al. AML1-FOG2 fusion protein in myelodysplasia. Blood. 2005;105:4523–6.
Sevov M, Bunikis I, Häggqvist S, Höglund M, Rosenquist R, Ameur A, et al. Targeted RNA sequencing assay efficiently identifies cryptic KMT2A (MLL)-fusions in acute leukemia patients. Blood. 2014;124:2406.
Maccaferri M, Pierini V, Di Giacomo D, Zucchini P, Forghieri F, Bonacorsi G, et al. The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes. Leuk Lymphoma. 2017;58:489–93.
Braekeleer ED, Férec C, Braekeleer MD. RUNX1 translocations in malignant hemopathies. Anticancer Res. 2009;29:1031–7.
Zaliova M, Moorman AV, Cazzaniga G, Stanulla M, Harvey RC, Roberts KG, et al. Characterization of leukemias with ETV6-ABL1 fusion. Haematologica. 2016;101:1082–93.
Harvey RC, Mullighan CG, Wang X, Dobbin KK, Davidson GS, Bedrick EJ, et al. Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood. 2010;116:4874–84.
Roberts KG, Li Y, Payne-Turner D, Harvey RC, Yang YL, Pei D, et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med. 2014;371:1005–15.